Mariano Serrao Selected Research

Mariano Serrao Research Topics

14	Migraine Disorders (Migraine) 01/2023 - 09/2005
11	Pain (Aches) 01/2023 - 09/2005
5	Stroke (Strokes) 01/2024 - 05/2012
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2011
3	Cerebellar Ataxia (Dysmetria) 06/2023 - 10/2017
3	Headache (Headaches) 10/2022 - 09/2005
2	Ataxia (Dyssynergia) 01/2023 - 10/2017
2	Cluster Headache (Cluster Headaches) 03/2022 - 01/2018
2	Chronic Pain 01/2019 - 01/2019
2	Prescription Drug Overuse 01/2019 - 01/2019
1	Spondylolisthesis 01/2024
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Congenital Abnormalities (Deformity) 08/2019
1	Weight Loss (Weight Reduction) 07/2019
1	Overweight 07/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Drug Resistant Epilepsy 01/2018
1	Paresis (Hemiparesis) 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Hepatolenticular Degeneration (Wilson's Disease) 03/2014
1	Dystonia (Limb Dystonia) 03/2014
1	Psychomotor Agitation (Akathisia) 09/2013
1	Parkinsonian Disorders (Parkinsonism) 09/2013
1	Dyskinesias (Dyskinesia) 09/2013
1	Psychotic Disorders (Schizoaffective Disorder) 09/2013
1	Movement Disorders (Movement Disorder) 09/2013
1	Secondary Headache Disorders 10/2012
1	Huntington Disease (Huntington's Disease) 08/2012
1	Aphasia (Dysphasia) 05/2012
1	Meningioma (Meningiomas) 05/2012
1	Glioblastoma (Glioblastoma Multiforme) 05/2012
1	Frontotemporal Dementia (Semantic Dementia) 08/2010
1	Epilepsy (Aura) 04/2010
1	Dementia (Dementias) 01/2002

5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 08/2013 - 09/2005
4	Type A Botulinum Toxins (Botox)FDA Link 01/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 04/2020
3	incobotulinumtoxinA FDA Link 01/2023 - 01/2018
2	PlasticsIBA 01/2019 - 12/2017
2	rotigotine FDA Link 11/2015 - 09/2013
2	Gabapentin (Neurontin)FDA LinkGeneric 03/2014 - 01/2002
2	Levodopa (L Dopa)FDA LinkGeneric 10/2013 - 02/2011
1	erenumabIBA 10/2022
1	AntibodiesIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 04/2020
1	KetonesIBA 07/2019
1	Therapeutic UsesIBA 07/2019
1	amsonic acid (DAS)IBA 01/2019
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2019
1	Topiramate (Topamax)FDA LinkGeneric 10/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 10/2016
1	Escitalopram FDA Link 04/2014
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2013
1	Antipsychotic Agents (Antipsychotics)IBA 09/2013
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2013
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2012
1	EndocannabinoidsIBA 10/2012
1	EnzymesIBA 10/2012
1	anandamide (arachidonylethanolamide)IBA 10/2012
1	HydrolasesIBA 10/2012
1	Nitric Oxide DonorsIBA 05/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 05/2011
1	ProgranulinsIBA 08/2010
1	Pain-FreeIBA 09/2005

5	Neurological Rehabilitation 01/2024 - 10/2017
4	Therapeutics 01/2021 - 10/2016
4	Ketogenic Diet 07/2019 - 01/2016
3	Diffuse Noxious Inhibitory Control 08/2013 - 09/2005
2	Transcranial Magnetic Stimulation 01/2019 - 09/2013
1	Minimally Invasive Surgical Procedures 01/2024
1	Deep Brain Stimulation 03/2022
1	Vagus Nerve Stimulation 03/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2021
1	Operative Surgical Procedures 08/2019
1	Caloric Restriction 07/2019
1	Pain Management 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Transcranial Direct Current Stimulation 12/2017
1	Drug Therapy (Chemotherapy) 10/2016
1	Transdermal Patch 11/2015
1	Activities of Daily Living (ADL) 05/2012
1	Speech Therapy (Therapy, Speech) 05/2012